SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Wave Life Sciences announces GSK selection of siRNA program for transition

Wave Life Sciences said GSK selected its siRNA program to transition to GSK for further development.

WVE

Related stories